EDRH
GSK icon

Edmond de Rothschild Holding’s GSK GSK Stock Holding History

Edmond de Rothschild Holding’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-464
Closed -$22K – 855
2021
Q3 		$22K Buy
+464
New +$23.3K ﹤0.01% 743
2016
Q3 		– Sell
-455
Closed -$25K – 863
2016
Q2 		$25K Hold
455
– – ﹤0.01% 705
2016
Q1 		$23K Hold
455
– – ﹤0.01% 706
2015
Q4 		$23K Hold
455
– – ﹤0.01% 708
2015
Q3 		$22K Hold
455
– – ﹤0.01% 701
2015
Q2 		$24K Buy
+455
New +$25.6K ﹤0.01% 713

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Edmond de Rothschild Holding's GSK Position: Q4 2021 in Review

Edmond de Rothschild Holding sold out of GSK (GSK) in Q4 2021, closing a stake of 464 shares — an estimated $22K sold.

Edmond de Rothschild Holding first reported a position in GSK in Q2 2015 and held it in 6 quarters. The position peaked at $25K in Q2 2016. 919 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

  • Edmond de Rothschild Holding reported no remaining GSK position as of Q4 2021 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 464 GSK shares in Q4 2021, an estimated $22K.
  • Edmond de Rothschild Holding first reported a position in GSK in Q2 2015 and held it in 6 quarters.
  • Edmond de Rothschild Holding's GSK position peaked at $25K in Q2 2016.
  • 919 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2021, filed 10 Feb 2022.